Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 57
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Clin Infect Dis ; 78(4): 860-866, 2024 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-37971399

RESUMO

Large language models (LLMs) are artificial intelligence systems trained by deep learning algorithms to process natural language and generate text responses to user prompts. Some approach physician performance on a range of medical challenges, leading some proponents to advocate for their potential use in clinical consultation and prompting some consternation about the future of cognitive specialties. However, LLMs currently have limitations that preclude safe clinical deployment in performing specialist consultations, including frequent confabulations, lack of contextual awareness crucial for nuanced diagnostic and treatment plans, inscrutable and unexplainable training data and methods, and propensity to recapitulate biases. Nonetheless, considering the rapid improvement in this technology, growing calls for clinical integration, and healthcare systems that chronically undervalue cognitive specialties, it is critical that infectious diseases clinicians engage with LLMs to enable informed advocacy for how they should-and shouldn't-be used to augment specialist care.


Assuntos
Doenças Transmissíveis , Rotulagem de Medicamentos , Humanos , Inteligência Artificial , Doenças Transmissíveis/diagnóstico , Idioma , Encaminhamento e Consulta
2.
Clin Infect Dis ; 78(1): 188-198, 2024 01 25.
Artigo em Inglês | MEDLINE | ID: mdl-37590953

RESUMO

The optimal treatment of prosthetic joint infection (PJI) remains uncertain. Patients undergoing debridement, antibiotics, and implant retention (DAIR) receive extended antimicrobial treatment, and some experts leave patients at perceived highest risk of relapse on suppressive antibiotic therapy (SAT). In this narrative review, we synthesize the literature concerning the role of SAT to prevent treatment failure following DAIR, attempting to answer 3 key questions: (1) What factors identify patients at highest risk for treatment failure after DAIR (ie, patients with the greatest potential to benefit from SAT), (2) Does SAT reduce the rate of treatment failure after DAIR, and (3) What are the rates of treatment failure and adverse events necessitating treatment discontinuation in patients receiving SAT? We conclude by proposing risk-benefit stratification criteria to guide use of SAT after DAIR for PJI, informed by the limited available literature.


Assuntos
Artrite Infecciosa , Infecções Relacionadas à Prótese , Humanos , Antibacterianos/uso terapêutico , Resultado do Tratamento , Desbridamento , Estudos Retrospectivos , Falha de Tratamento , Artrite Infecciosa/tratamento farmacológico , Infecções Relacionadas à Prótese/tratamento farmacológico , Infecções Relacionadas à Prótese/cirurgia
3.
Clin Infect Dis ; 76(2): 346-350, 2023 01 13.
Artigo em Inglês | MEDLINE | ID: mdl-36056891

RESUMO

Group A Streptococcus (GAS) necrotizing soft tissue infections and toxic shock syndrome remain high-mortality conditions. In vitro and animal model data, as well as multiple observational studies, suggest adjunctive clindamycin (ie, given with a beta-lactam) reduces invasive GAS infection mortality by inhibiting exotoxin production. Unfortunately, clindamycin resistance in GAS has been rapidly increasing in the United States since the mid-2010s, although the clinical significance of this remains unclear. Linezolid is a promising alternative adjunctive agent to which US GAS isolates remain near-universally susceptible, with a similar mechanism of action and similar in vitro evidence of GAS virulence factor attenuation. However, the clinical data supporting linezolid's value in severe GAS infections are far more limited. Here the authors review the data and reasoning behind a general preference for clindamycin or linezolid in a focused, pro-con debate format.


Assuntos
Anti-Infecciosos , Fasciite Necrosante , Choque Séptico , Infecções dos Tecidos Moles , Infecções Estreptocócicas , Animais , Clindamicina/farmacologia , Clindamicina/uso terapêutico , Linezolida/farmacologia , Linezolida/uso terapêutico , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Choque Séptico/tratamento farmacológico , Infecções dos Tecidos Moles/tratamento farmacológico , Infecções Estreptocócicas/tratamento farmacológico , Streptococcus pyogenes
4.
Antimicrob Agents Chemother ; 67(10): e0063623, 2023 10 18.
Artigo em Inglês | MEDLINE | ID: mdl-37787556

RESUMO

Human noroviruses (HuNoVs) are the leading cause of acute gastroenteritis. In immunocompetent hosts, symptoms usually resolve within 3 days; however, in immunocompromised persons, HuNoV infection can become persistent, debilitating, and sometimes life-threatening. There are no licensed therapeutics for HuNoV due to a near half-century delay in its cultivation. Treatment for chronic HuNoV infection in immunosuppressed patients anecdotally includes nitazoxanide, a broad-spectrum antimicrobial licensed for treatment of parasite-induced gastroenteritis. Despite its off-label use for chronic HuNoV infection, nitazoxanide has not been clearly demonstrated to be an effective treatment. In this study, we standardized a pipeline for antiviral testing using multiple human small intestinal enteroid lines representing different intestinal segments and evaluated whether nitazoxanide inhibits replication of five HuNoV strains in vitro. Nitazoxanide did not exhibit high selective antiviral activity against any HuNoV strain tested, indicating it is not an effective antiviral for HuNoV infection. Human intestinal enteroids are further demonstrated as a model to serve as a preclinical platform to test antivirals against HuNoVs to treat gastrointestinal disease. Abstr.


Assuntos
Infecções por Caliciviridae , Gastroenterite , Norovirus , Humanos , Gastroenterite/tratamento farmacológico , Antivirais/farmacologia , Antivirais/uso terapêutico , Padrões de Referência , Infecções por Caliciviridae/tratamento farmacológico , Replicação Viral
5.
Clin Infect Dis ; 75(8): 1457-1461, 2022 10 12.
Artigo em Inglês | MEDLINE | ID: mdl-35535794

RESUMO

Staphylococcus aureus bacteremia (SAB) causes considerable morbidity and mortality and requires comprehensive assessment for metastatic infection. The roles of routine imaging beyond echocardiography in SAB, including 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT), remain contentious. We performed a literature review of studies reporting impact of 18F-FDG-PET/CT on the clinical management or outcomes of SAB published through 1 March 2022. We identified 7 observational studies in which 18F-FDG-PET/CT frequently identified metastatic foci of infection, revealed foci undetected by prior investigations, led to additional source control procedures, and was associated with fewer infection relapses and lower mortality. Calculated numbers needed to treat for receipt of 18F-FDG-PET/CT were 7-9 to change antimicrobial therapy, 10-27 to lead to an additional source control procedure, and 4-8 to prevent death. These data are comparable to the evidence for clinical impact of other diagnostic modalities accepted as standard of care in SAB, and form a compelling basis for advocacy to expand access to 18F-FDG-PET/CT.


Assuntos
Anti-Infecciosos , Bacteriemia , Neoplasias , Infecções Estafilocócicas , Idoso , Bacteriemia/diagnóstico por imagem , Bacteriemia/tratamento farmacológico , Fluordesoxiglucose F18 , Glucose , Humanos , Medicare , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada/métodos , Tomografia por Emissão de Pósitrons , Compostos Radiofarmacêuticos , Infecções Estafilocócicas/diagnóstico por imagem , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus , Estados Unidos
6.
Clin Infect Dis ; 74(Suppl_3): S244-S250, 2022 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-35568479

RESUMO

BACKGROUND: Journal clubs have been an enduring mainstay of medical education, and hosting these on social media platforms can expand accessibility and engagement. We describe the creation and impact of #IDJClub, an infectious diseases (ID) Twitter journal club. METHODS: We launched #IDJClub in October 2019. Using the account @IDJClub, an ID physician leads a 1-hour open-access Twitter discussion of a recent publication. All participants use the hashtag #IDJClub. Sessions started monthly, but increased due to demand during the coronavirus disease 2019 (COVID-19) pandemic. We used Symplur 's Healthcare Hashtag project to track engagement of #IDJClub per 60-minute discussion plus the following 30 minutes to capture ongoing conversations. We also conducted an online anonymous survey using Likert scales and open-ended questions to assess educational impact. RESULTS: In its first 20 months, 31 journal clubs were held, with medians of 42 (interquartile range [IQR], 28.5-60) participants and 312 (IQR, 205-427.5) tweets per session. 134 participants completed the survey, of whom 39% were ID physicians, 19% pharmacists, 13% ID fellows, and 10% medical residents. Most agreed or strongly agreed that #IDJClub provided clinically useful knowledge (95%), increased personal confidence in independent literature appraisal (72%), and was more educational than traditional journal clubs (72%). The format addressed several barriers to traditional journal club participation such as lack of access, subject experts, and time. CONCLUSIONS: #IDJClub is an effective virtual journal club, providing an engaging, open-access tool for critical literature appraisal that overcomes several barriers to traditional journal club participations while fostering connectedness within the global ID community.


Assuntos
COVID-19 , Doenças Transmissíveis , Educação Médica , Médicos , Mídias Sociais , Doenças Transmissíveis/epidemiologia , Humanos
7.
Clin Infect Dis ; 74(Suppl_3): S229-S236, 2022 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-35568477

RESUMO

Social media platforms have revolutionized how we consume information, along with how to effectively present communication, education, and advocacy efforts. There is profound value in leveraging social media within these aspects for the field of infectious diseases, for divisions and individual clinicians. Herein, we provide the rationale to incorporate social media as a key competency for infectious diseases training and specific guidance on aspects of education and strategic development of new accounts critical for success.


Assuntos
Doenças Transmissíveis , Mídias Sociais , Doenças Transmissíveis/terapia , Humanos
8.
Clin Infect Dis ; 74(Suppl_3): S237-S243, 2022 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-35568480

RESUMO

Social media (SoMe) platforms have been increasingly used by infectious diseases (ID) learners and educators in recent years. This trend has only accelerated with the changes brought to our educational spaces by the coronavirus disease 2019 pandemic. Given the increasingly diverse SoMe landscape, educators may find themselves struggling with how to effectively use these tools. In this Viewpoint we describe how to use SoMe platforms (e.g., Twitter, podcasts, and open-access online content portals) in medical education, highlight medical education theories supporting their use, and discuss how educators can engage with these learning tools effectively. We focus on how these platforms harness key principles of adult learning and provide a guide for educators in the effective use of SoMe tools in educating ID learners. Finally, we suggest how to effectively interact with and leverage these increasingly important digital platforms.


Assuntos
COVID-19 , Doenças Transmissíveis , Educação Médica , Mídias Sociais , Humanos , Aprendizagem
9.
Clin Infect Dis ; 68(6): 1011-1016, 2019 03 05.
Artigo em Inglês | MEDLINE | ID: mdl-29986016

RESUMO

BACKGROUND: An estimated 6500 undocumented immigrants with end-stage renal disease (ESRD) live in the United States. Those living in states that do not provide undocumented immigrants scheduled hemodialysis receive intermittent hemodialysis only when life-threatening conditions arise. Little is known about catheter-related bloodstream infections (CRBSIs) in this population. METHODS: We conducted a retrospective cohort study of emergency-only hemodialysis patients in the Harris Health System in Houston, Texas, between January 2012 and December 2015. We assessed CRBSI risk factors including demographics, comorbidities, and duration and frequency of hemodialysis. We investigated the microbiologic etiology of these infections, rates of recurrent CRBSI, and associated morbidity and mortality. RESULTS: The cohort included 329 patients; 90% were Hispanic, 60% had diabetes, and the average age was 51 years. A total of 101 CRBSIs occurred, with a rate of 0.84 infections per 1000 catheter-days. Cirrhosis and duration of hemodialysis during the study period were associated with increased risk of CRBSI. Seventeen CRBSIs were recurrent; infection with gram-positive bacteria predicted recurrence. Adherence to catheter-related infection guidelines was improved by infectious diseases consultation and associated with fewer recurrent infections. CRBSI was associated with prolonged hospitalization (mean, 15 days), composite complication rate of 8%, and a 4% mortality rate. CONCLUSIONS: Patients receiving emergency-only hemodialysis via tunneled catheters have a high CRBSI rate compared with infection rates previously reported in patients receiving scheduled maintenance hemodialysis. Increased CRSBI risk likely contributes to the increased morbidity and mortality seen in ESRD patients receiving emergency-only hemodialysis.


Assuntos
Infecções Relacionadas a Cateter/epidemiologia , Serviços Médicos de Emergência , Diálise Renal/efeitos adversos , Sepse/epidemiologia , Sepse/etiologia , Adulto , Idoso , Infecções Relacionadas a Cateter/diagnóstico , Estudos de Coortes , Gerenciamento Clínico , Feminino , Humanos , Falência Renal Crônica/complicações , Falência Renal Crônica/epidemiologia , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
13.
Nature ; 485(7397): 256-9, 2012 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-22504179

RESUMO

As with many other viruses, the initial cell attachment of rotaviruses, which are the major causative agent of infantile gastroenteritis, is mediated by interactions with specific cellular glycans. The distally located VP8* domain of the rotavirus spike protein VP4 (ref. 5) mediates such interactions. The existing paradigm is that 'sialidase-sensitive' animal rotavirus strains bind to glycans with terminal sialic acid (Sia), whereas 'sialidase-insensitive' human rotavirus strains bind to glycans with internal Sia such as GM1 (ref. 3). Although the involvement of Sia in the animal strains is firmly supported by crystallographic studies, it is not yet known how VP8* of human rotaviruses interacts with Sia and whether their cell attachment necessarily involves sialoglycans. Here we show that VP8* of a human rotavirus strain specifically recognizes A-type histo-blood group antigen (HBGA) using a glycan array screen comprised of 511 glycans, and that virus infectivity in HT-29 cells is abrogated by anti-A-type antibodies as well as significantly enhanced in Chinese hamster ovary cells genetically modified to express the A-type HBGA, providing a novel paradigm for initial cell attachment of human rotavirus. HBGAs are genetically determined glycoconjugates present in mucosal secretions, epithelia and on red blood cells, and are recognized as susceptibility and cell attachment factors for gastric pathogens like Helicobacter pylori and noroviruses. Our crystallographic studies show that the A-type HBGA binds to the human rotavirus VP8* at the same location as the Sia in the VP8* of animal rotavirus, and suggest how subtle changes within the same structural framework allow for such receptor switching. These results raise the possibility that host susceptibility to specific human rotavirus strains and pathogenesis are influenced by genetically controlled expression of different HBGAs among the world's population.


Assuntos
Sistema ABO de Grupos Sanguíneos/metabolismo , Especificidade de Hospedeiro/fisiologia , Proteínas de Ligação a RNA/metabolismo , Receptores Virais/metabolismo , Rotavirus , Proteínas não Estruturais Virais/metabolismo , Sistema ABO de Grupos Sanguíneos/química , Sistema ABO de Grupos Sanguíneos/genética , Sistema ABO de Grupos Sanguíneos/imunologia , Sequência de Aminoácidos , Animais , Células CHO , Cricetinae , Cristalografia por Raios X , Eritrócitos/metabolismo , Eritrócitos/virologia , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Ácido N-Acetilneuramínico/antagonistas & inibidores , Ácido N-Acetilneuramínico/química , Ácido N-Acetilneuramínico/imunologia , Ácido N-Acetilneuramínico/metabolismo , Proteínas de Ligação a RNA/química , Receptores Virais/química , Receptores Virais/genética , Rotavirus/química , Rotavirus/classificação , Rotavirus/metabolismo , Rotavirus/patogenicidade , Proteínas não Estruturais Virais/química
14.
Infect Dis Clin Pract (Baltim Md) ; 25(3): e9-e11, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-30906173

RESUMO

Arcanbacterium haemolyticum is an uncommon cause of pharyngitis with rash that occurs predominantly among adolescents and that has been only rarely implicated in severe or systemic infections. We report a case of subdural empyema and bacteremia due to A. haemolyticum in an adolescent woman following physical assault with trauma to the head, which required neurosurgical intervention combined with prolonged antibiotic therapy. We additionally describe the previous occurrences of A. haemolyticum culture positivity recorded over a fifteen-year period by the microbiology laboratories of the two large academic medical centers at which this patient received care, and review the epidemiology, laboratory identification, and treatment of this unusual pathogen.

19.
J Virol ; 87(13): 7255-64, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23616650

RESUMO

Naturally occurring bovine-human reassortant rotaviruses with a P[11] VP4 genotype exhibit a tropism for neonates. Interaction of the VP8* domain of the spike protein VP4 with sialic acid was thought to be the key mediator for rotavirus infectivity. However, recent studies have indicated a role for nonsialylated glycoconjugates, including histo-blood group antigens (HBGAs), in the infectivity of human rotaviruses. We sought to determine if the bovine rotavirus-derived VP8* of a reassortant neonatal G10P[11] virus interacts with hitherto uncharacterized glycans. In an array screen of >600 glycans, VP8* P[11] showed specific binding to glycans with the Galß1-4GlcNAc motif, which forms the core structure of type II glycans and is the precursor of H type II HBGA. The specificity of glycan binding was confirmed through hemagglutination assays; GST-VP8* P[11] hemagglutinates type O, A, and B red blood cells as well as pooled umbilical cord blood erythrocytes. Further, G10P[11] infectivity was significantly enhanced by the expression of H type II HBGA in CHO cells. The bovine-origin VP4 was confirmed to be essential for this increased infectivity, using laboratory-derived reassortant viruses generated from sialic acid binding rotavirus SA11-4F and a bovine G10P[11] rotavirus, B223. The binding to a core glycan unit has not been reported for any rotavirus VP4. Core glycan synthesis is constitutive in most cell types, and modification of these glycans is thought to be developmentally regulated. These studies provide the first molecular basis for understanding neonatal rotavirus infections, indicating that glycan modification during neonatal development may mediate the age-restricted infectivity of neonatal viruses.


Assuntos
Proteínas do Capsídeo/genética , Proteínas do Capsídeo/metabolismo , Doenças do Recém-Nascido/virologia , Polissacarídeos/metabolismo , Infecções por Rotavirus/metabolismo , Rotavirus/genética , Animais , Células CHO , Bovinos , Cricetinae , Cricetulus , Testes de Hemaglutinação , Humanos , Recém-Nascido , Ácido N-Acetilneuramínico/metabolismo , Estrutura Terciária de Proteína/genética , Infecções por Rotavirus/genética , Ligação Viral
20.
Am J Public Health ; 104(11): 2060-5, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24328628

RESUMO

A growing body of literature defends the efficacy of seasonal influenza vaccination for health care workers in reducing the mortality of hospitalized patients. I review the evidence concerning influenza vaccination, concluding that universal vaccination of health care workers against influenza should be considered standard patient care and that nonvaccination represents maleficent care. I further argue that the ethical responsibility to ensure universal vaccination of staff against seasonal influenza lies not only with individual health care providers but with each individual health care institution.


Assuntos
Pessoal de Saúde/normas , Transmissão de Doença Infecciosa do Profissional para o Paciente/prevenção & controle , Vacinas contra Influenza/uso terapêutico , Influenza Humana/prevenção & controle , Programas Obrigatórios , Segurança do Paciente/normas , Pessoal de Saúde/ética , Humanos , Transmissão de Doença Infecciosa do Profissional para o Paciente/ética , Programas Obrigatórios/ética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA